The Pharmaceutical Supply Chain Initiative (PSCI) Audit Findings 2025 report reveals critical insights into manufacturing excellence across the global pharmaceutical supply chain. This comprehensive analysis of 2,046 findings from 228 audits conducted in 2024, combined with five-year trend data encompassing nearly 7,700 findings from 641 audits, illuminates persistent challenges in Health & Safety, Governance & Management Systems, Human Rights, Environment, and Ethics. While these findings reflect the current state of supplier practices, they also underscore an essential truth: the quality, expertise, and approach of the auditing firm directly determine whether these challenges translate into meaningful improvements or remain persistent vulnerabilities. This paper examines the key findings from the PSCI 2025 report and demonstrates how partnering with the right PSCI auditing firm can transform audit observations into sustainable operational excellence and risk mitigation…(Download the PDF )
